<p>Artivion（纽约证券交易所代码：AORT - 获取免费报告）在周六发布的研究报告中被华尔街 Zen 从 “强力买入” 评级下调至 “买入” 评级。</p>
<p>其他几家券商最近也对 AORT 发布了报告。Stifel Nicolaus 将 Artivion 的目标价格从 40.00 美元上调至 46.00 美元，并在 9 月 29 日的报告中给予该股票 “买入” 评级。Canaccord Genuity Group 将 Artivion 的目标价格从 50.00 美元上调至 51.00 美元，并在 11 月 7 日的研究报告中给予该公司 “买入” 评级。Needham &amp; Company LLC 将 Artivion 的目标价格从 50.00 美元上调至 58.00 美元，并在 11 月 7 日的报告中给予该股票 “买入” 评级。Citizens Jmp 将 Artivion 的目标价格从 47.00 美元上调至 53.00 美元，并在 11 月 7 日的研究报告中给予该公司 “市场表现优于大盘” 评级。最后，Oppenheimer 在 11 月 7 日的研究报告中重申了 “跑赢大盘” 评级，并对 Artivion 的股票设定了 50.00 美元的目标价格。七位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，Artivion 目前的共识评级为 “适度买入”，平均目标价格为 49.11 美元。</p>
<p><strong>查看我们关于 Artivion 的最新报告</strong></p>
<h2>Artivion 股价下跌 0.7%</h2>
<p>Artivion 的股票在周五开盘价为 45.16 美元。Artivion 的 12 个月低点为 21.97 美元，12 个月高点为 48.04 美元。该公司的市值为 21.4 亿美元，市盈率为-188.17，贝塔系数为 1.60。该公司的 50 日简单移动平均线为 44.34 美元，200 日简单移动平均线为 38.65 美元。该公司的流动比率为 3.93，速动比率为 2.88，债务与股本比率为 0.50。</p>
<p>Artivion（纽约证券交易所代码：AORT - 获取免费报告）最近在 11 月 6 日发布了季度财报。该公司报告每股收益（EPS）为 0.16 美元，超出市场共识预期的 0.14 美元，超出幅度为 0.02 美元。Artivion 的股本回报率为 5.98%，净利润率为-2.16%。该公司在本季度的收入为 1.1339 亿美元，而分析师预期为 1.1071 亿美元。该公司的季度收入同比增长 18.9%。整体来看，股票分析师预测 Artivion 在当前财政年度的每股收益为 0.37 美元。</p>
<h2>Artivion 的内部买卖情况</h2>
<p>在其他新闻中，董事 Elizabeth A. Hoff 在 11 月 18 日的交易中出售了 4200 股该股票。该股票的平均售价为 45.10 美元，总交易额为 189,420.00 美元。交易后，该董事直接持有公司股票 27,189 股，价值 1,226,223.90 美元。这代表其持股比例减少了 13.38%。该交易已在证券交易委员会的备案中披露，相关信息可通过此链接获取。此外，SVP Jean F. Holloway 在 12 月 3 日的交易中出售了 7315 股 Artivion 股票。该股票的平均售价为 45.30 美元，总价值为 331,369.50 美元。交易完成后，该高级副总裁直接持有公司股票 156,093 股，价值 7,071,012.90 美元。该交易使其持股比例减少了 4.48%。该销售的披露信息可在 SEC 备案中找到。在过去 90 天内，内部人士出售了 234,511 股公司股票，价值 10,612,452 美元。7.60% 的股票由公司内部人士持有。</p>
<h2>对 Artivion 的对冲基金看法</h2>
<p>几家机构投资者最近对该公司的持股进行了调整。先锋集团（Vanguard Group Inc.）在第三季度将其在 Artivion 的持股增加了 8.3%。先锋集团目前持有该公司 3,029,059 股股票，价值 128,250,000 美元，此前在上个季度又购买了 232,424 股。威灵顿管理集团（Wellington Management Group LLP）在第一季度将其在 Artivion 的持股增加了 4.1%。威灵顿管理集团目前持有该公司 1,727,408 股股票，价值 42,460,000 美元，此前在该期间又收购了 67,327 股。Next Century Growth Investors LLC 在第一季度将其在 Artivion 的持股增加了 107.6%。Next Century Growth Investors LLC 目前持有该公司 1,022,775 股股票，价值 25,140,000 美元，此前在该期间又收购了 530,122 股。美国银行（Bank of America Corp DE）在第二季度将其在 Artivion 的持股增加了 22.8%。美国银行目前持有该公司 645,070 股股票，价值 20,062,000 美元，此前在上个季度又收购了 119,634 股。最后，景顺（Invesco Ltd.）在第二季度将其在 Artivion 的持股增加了 40.8%。景顺目前持有该公司 481,026 股股票，价值 14,960,000 美元，此前在该期间又收购了 139,370 股。机构投资者持有该公司 86.37% 的股票。</p>
<h2>关于 Artivion</h2>
<p>（获取免费报告）</p>
<p>Artivion, Inc.在全球范围内制造、加工和分销医疗设备和可植入的人体组织。该公司提供 BioGlue，这是一种由牛血蛋白和交联蛋白的试剂组成的聚合物，适用于心脏、血管、神经和肺部手术；心脏保护服务；PhotoFix，一种牛心包补片；以及包括 E-vita Open Plus 和 E-vita Open Neo 在内的主动脉弓支架。</p>
<h2>相关文章</h2>
<ul>
<li>五只我们更看好的股票比 Artivion 更好</li>
<li>在投资中下调评级意味着什么？</li>
<li>Synopsys 因 Ansys 整合推动增长而看涨</li>
<li>如何使用 MarketBeat 股票筛选器</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
<li>三只可以帮助抵御通货膨胀的食品杂货股票</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Artivion 吗？</h2>
<p>在考虑 Artivion 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Artivion 并不在名单上。</p>
<p>虽然 Artivion 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AORT

<p>华尔街禅将 Artivion（纽约证券交易所代码：AORT）的评级从 “强力买入” 下调至 “买入”。其他券商，包括 Stifel Nicolaus、Canaccord Genuity Group、Needham & Company LLC、Citizens Jmp 和 Oppenheimer，维持或上调了对 Artivion 的目标价和买入评级。该公司报告了积极的盈利和收入增长。内部人士最近出售了股份，而几家机构投资者则增加了在该公司的持仓</p>

<p>Artivion (NYSE:AORT - Get Free Report) was downgraded by Wall Street Zen from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report issued on Saturday.</p>
<div class="lb-trans"><p>Artivion（纽约证券交易所代码：AORT - 获取免费报告）在周六发布的研究报告中被华尔街 Zen 从 “强力买入” 评级下调至 “买入” 评级。</p>
</div><p>Several other brokerages have also recently issued reports on AORT. Stifel Nicolaus lifted their target price on shares of Artivion from $40.00 to $46.00 and gave the stock a &#34;buy&#34; rating in a report on Monday, September 29th. Canaccord Genuity Group raised their price target on shares of Artivion from $50.00 to $51.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, November 7th. Needham &amp; Company LLC boosted their price objective on shares of Artivion from $50.00 to $58.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, November 7th. Citizens Jmp increased their target price on Artivion from $47.00 to $53.00 and gave the company a &#34;market outperform&#34; rating in a research note on Friday, November 7th. Finally, Oppenheimer restated an &#34;outperform&#34; rating and issued a $50.00 price target on shares of Artivion in a research note on Friday, November 7th. Seven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Artivion currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $49.11.</p>
<div class="lb-trans"><p>其他几家券商最近也对 AORT 发布了报告。Stifel Nicolaus 将 Artivion 的目标价格从 40.00 美元上调至 46.00 美元，并在 9 月 29 日的报告中给予该股票 “买入” 评级。Canaccord Genuity Group 将 Artivion 的目标价格从 50.00 美元上调至 51.00 美元，并在 11 月 7 日的研究报告中给予该公司 “买入” 评级。Needham &amp; Company LLC 将 Artivion 的目标价格从 50.00 美元上调至 58.00 美元，并在 11 月 7 日的报告中给予该股票 “买入” 评级。Citizens Jmp 将 Artivion 的目标价格从 47.00 美元上调至 53.00 美元，并在 11 月 7 日的研究报告中给予该公司 “市场表现优于大盘” 评级。最后，Oppenheimer 在 11 月 7 日的研究报告中重申了 “跑赢大盘” 评级，并对 Artivion 的股票设定了 50.00 美元的目标价格。七位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，Artivion 目前的共识评级为 “适度买入”，平均目标价格为 49.11 美元。</p>
</div><p><strong>View Our Latest Report on Artivion</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Artivion 的最新报告</strong></p>
</div><h2>Artivion Trading Down 0.7%</h2>
<div class="lb-trans"><h2>Artivion 股价下跌 0.7%</h2>
</div><p>Artivion stock opened at $45.16 on Friday. Artivion has a 12 month low of $21.97 and a 12 month high of $48.04. The company has a market capitalization of $2.14 billion, a price-to-earnings ratio of -188.17 and a beta of 1.60. The business's fifty day simple moving average is $44.34 and its two-hundred day simple moving average is $38.65. The company has a current ratio of 3.93, a quick ratio of 2.88 and a debt-to-equity ratio of 0.50.</p>
<div class="lb-trans"><p>Artivion 的股票在周五开盘价为 45.16 美元。Artivion 的 12 个月低点为 21.97 美元，12 个月高点为 48.04 美元。该公司的市值为 21.4 亿美元，市盈率为-188.17，贝塔系数为 1.60。该公司的 50 日简单移动平均线为 44.34 美元，200 日简单移动平均线为 38.65 美元。该公司的流动比率为 3.93，速动比率为 2.88，债务与股本比率为 0.50。</p>
</div><p>Artivion (NYSE:AORT - Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.02. Artivion had a positive return on equity of 5.98% and a negative net margin of 2.16%.The firm had revenue of $113.39 million during the quarter, compared to analyst estimates of $110.71 million. The company's quarterly revenue was up 18.9% on a year-over-year basis. As a group, equities analysts predict that Artivion will post 0.37 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Artivion（纽约证券交易所代码：AORT - 获取免费报告）最近在 11 月 6 日发布了季度财报。该公司报告每股收益（EPS）为 0.16 美元，超出市场共识预期的 0.14 美元，超出幅度为 0.02 美元。Artivion 的股本回报率为 5.98%，净利润率为-2.16%。该公司在本季度的收入为 1.1339 亿美元，而分析师预期为 1.1071 亿美元。该公司的季度收入同比增长 18.9%。整体来看，股票分析师预测 Artivion 在当前财政年度的每股收益为 0.37 美元。</p>
</div><h2>Insider Buying and Selling at Artivion</h2>
<div class="lb-trans"><h2>Artivion 的内部买卖情况</h2>
</div><p>In other news, Director Elizabeth A. Hoff sold 4,200 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $45.10, for a total transaction of $189,420.00. Following the transaction, the director directly owned 27,189 shares of the company's stock, valued at $1,226,223.90. This represents a 13.38% decrease in their position. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. Also, SVP Jean F. Holloway sold 7,315 shares of Artivion stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $45.30, for a total value of $331,369.50. Following the completion of the sale, the senior vice president directly owned 156,093 shares of the company's stock, valued at $7,071,012.90. The trade was a 4.48% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 234,511 shares of company stock worth $10,612,452. 7.60% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他新闻中，董事 Elizabeth A. Hoff 在 11 月 18 日的交易中出售了 4200 股该股票。该股票的平均售价为 45.10 美元，总交易额为 189,420.00 美元。交易后，该董事直接持有公司股票 27,189 股，价值 1,226,223.90 美元。这代表其持股比例减少了 13.38%。该交易已在证券交易委员会的备案中披露，相关信息可通过此链接获取。此外，SVP Jean F. Holloway 在 12 月 3 日的交易中出售了 7315 股 Artivion 股票。该股票的平均售价为 45.30 美元，总价值为 331,369.50 美元。交易完成后，该高级副总裁直接持有公司股票 156,093 股，价值 7,071,012.90 美元。该交易使其持股比例减少了 4.48%。该销售的披露信息可在 SEC 备案中找到。在过去 90 天内，内部人士出售了 234,511 股公司股票，价值 10,612,452 美元。7.60% 的股票由公司内部人士持有。</p>
</div><h2>Hedge Funds Weigh In On Artivion</h2>
<div class="lb-trans"><h2>对 Artivion 的对冲基金看法</h2>
</div><p>Several institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of Artivion by 8.3% in the third quarter. Vanguard Group Inc. now owns 3,029,059 shares of the company's stock worth $128,250,000 after buying an additional 232,424 shares during the last quarter. Wellington Management Group LLP raised its position in Artivion by 4.1% in the first quarter. Wellington Management Group LLP now owns 1,727,408 shares of the company's stock worth $42,460,000 after acquiring an additional 67,327 shares during the period. Next Century Growth Investors LLC raised its position in Artivion by 107.6% in the first quarter. Next Century Growth Investors LLC now owns 1,022,775 shares of the company's stock worth $25,140,000 after acquiring an additional 530,122 shares during the period. Bank of America Corp DE boosted its stake in shares of Artivion by 22.8% during the 2nd quarter. Bank of America Corp DE now owns 645,070 shares of the company's stock worth $20,062,000 after acquiring an additional 119,634 shares during the last quarter. Finally, Invesco Ltd. grew its position in shares of Artivion by 40.8% during the 2nd quarter. Invesco Ltd. now owns 481,026 shares of the company's stock valued at $14,960,000 after acquiring an additional 139,370 shares during the period. Institutional investors own 86.37% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者最近对该公司的持股进行了调整。先锋集团（Vanguard Group Inc.）在第三季度将其在 Artivion 的持股增加了 8.3%。先锋集团目前持有该公司 3,029,059 股股票，价值 128,250,000 美元，此前在上个季度又购买了 232,424 股。威灵顿管理集团（Wellington Management Group LLP）在第一季度将其在 Artivion 的持股增加了 4.1%。威灵顿管理集团目前持有该公司 1,727,408 股股票，价值 42,460,000 美元，此前在该期间又收购了 67,327 股。Next Century Growth Investors LLC 在第一季度将其在 Artivion 的持股增加了 107.6%。Next Century Growth Investors LLC 目前持有该公司 1,022,775 股股票，价值 25,140,000 美元，此前在该期间又收购了 530,122 股。美国银行（Bank of America Corp DE）在第二季度将其在 Artivion 的持股增加了 22.8%。美国银行目前持有该公司 645,070 股股票，价值 20,062,000 美元，此前在上个季度又收购了 119,634 股。最后，景顺（Invesco Ltd.）在第二季度将其在 Artivion 的持股增加了 40.8%。景顺目前持有该公司 481,026 股股票，价值 14,960,000 美元，此前在该期间又收购了 139,370 股。机构投资者持有该公司 86.37% 的股票。</p>
</div><h2>About Artivion</h2>
<div class="lb-trans"><h2>关于 Artivion</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Artivion, Inc manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo.</p>
<div class="lb-trans"><p>Artivion, Inc.在全球范围内制造、加工和分销医疗设备和可植入的人体组织。该公司提供 BioGlue，这是一种由牛血蛋白和交联蛋白的试剂组成的聚合物，适用于心脏、血管、神经和肺部手术；心脏保护服务；PhotoFix，一种牛心包补片；以及包括 E-vita Open Plus 和 E-vita Open Neo 在内的主动脉弓支架。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>相关文章</h2>
</div><ul>
<li>Five stocks we like better than Artivion</li>
<li>What Does Downgrade Mean in Investing?</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>How to Use the MarketBeat Stock Screener</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比 Artivion 更好</li>
<li>在投资中下调评级意味着什么？</li>
<li>Synopsys 因 Ansys 整合推动增长而看涨</li>
<li>如何使用 MarketBeat 股票筛选器</li>
<li>你能给自己最好的节日礼物是什么？Costco 股票</li>
<li>三只可以帮助抵御通货膨胀的食品杂货股票</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFPUlQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=AORT"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Artivion Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Artivion 吗？</h2>
</div><p>Before you consider Artivion, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Artivion 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Artivion wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Artivion 并不在名单上。</p>
</div><p>While Artivion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Artivion 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Artivion（NYSE:AORT）在 Wall Street Zen 被下调至 “买入” 评级